Led by world-class scientists, we are recognized as industry leaders in polymorphism research, crystallization process development, preclinical formulation development, particle engineering, and the co-purification of APIs and excipients. With over 160 years of combined experience at top global pharmaceutical companies, our crystallization experts and highly knowledgeable research scientists provide effective solutions to challenges related to polymorphism and crystallization processes within the CMC field. Committed to understanding fundamental principles and mechanisms, we leverage our knowledge and experience to offer tailored solutions for each stage of drug development.

Utilizing state-of-the-art instrumentation and equipment, we have provided solutions for polymorphism research on over 500 small molecules and developed crystallization processes for more than 200 organic compounds. At our Drug Crystallization Center, we have a team of well-rounded scientists who are specially trained to efficiently execute projects and regularly communicate directly with clients. Our project managers continuously adjust our resources to align with project timelines and development stages. Our focus is on delivering purpose-fit solutions within budget and on schedule.